Detalhe da pesquisa
1.
Renin and renin blockade have no role in complement activity.
Kidney Int
; 105(2): 328-337, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38008161
2.
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Am J Kidney Dis
; 79(4): 570-581, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34571062
3.
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
Kidney Int
; 100(4): 753-779, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34556300
4.
Eculizumab exposure in children and young adults: indications, practice patterns, and outcomes-a Pediatric Nephrology Research Consortium study.
Pediatr Nephrol
; 36(8): 2349-2360, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33693990
5.
Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.
Kidney Int
; 98(5): 1265-1274, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32540405
6.
Complement inhibition in C3 glomerulopathy.
Semin Immunol
; 28(3): 241-9, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27402056
7.
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Kidney Int
; 91(3): 539-551, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27989322
8.
Syndromes of thrombotic microangiopathy.
N Engl J Med
; 371(7): 654-66, 2014 Aug 14.
Artigo
Inglês
| MEDLINE | ID: mdl-25119611
9.
C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
Am J Kidney Dis
; 70(6): 834-843, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28838767
10.
Managing atypical hemolytic uremic syndrome: chapter 2.
Kidney Int
; 87(5): 882-4, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25951068
11.
After the Party's Over.
N Engl J Med
; 376(1): 74-80, 2017 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28052232
12.
Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.
Blood
; 122(8): 1487-93, 2013 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-23847193
13.
Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.
J Am Soc Nephrol
; 25(1): 55-64, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24029428
14.
Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.
J Am Soc Nephrol
; 24(11): 1820-9, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23907509
15.
Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy.
Kidney Int Rep
; 9(2): 464-477, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38344720
16.
C3 glomerulopathy: consensus report.
Kidney Int
; 84(6): 1079-89, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24172683
17.
Treatment options for C3 glomerulopathy.
Curr Opin Nephrol Hypertens
; 22(2): 231-7, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23318699
18.
Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
Curr Opin Pediatr
; 25(2): 225-31, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23486421
19.
A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome.
Pediatr Nephrol
; 28(11): 2221-5, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23880784
20.
Diagnosis and treatment of C3 glomerulopathy.
Clin Nephrol
; 80(6): 395-403, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23993166